Méaban. Soon provider of pharmaceutical industry
By consolidating its partnerships with other manufacturers, the group operates in Vannes Méaban diversification. Which relies on local reinvestment.
Very quickly, the group should achieve Méaban 50% of its turnover abroad. Against 35% today. This is what aims Frederic Lescure, Chairman and CEO of this "micro-multinational" as he calls himself. This goal will be easily accessible by successive acquisitions of North American partners as MagChem, and Dysol Dynamold. And more recently to Babb Co Fun (78). By integrating it with the holding in December, Méaban completes its range of chemical solutions and techniques from upstream to downstream.
New markets in energy
Indeed, Babb Co (six million euros in turnover, 31 employees) has made a specialty of nondestructive control solutions. A somewhat complex term that designates a fluorescent fluid to distinguish embrittling elements of a structure. Once immersed in a bath of control, a wing of an airplane engine reveals its flaws and weakness. Adding control to the cleaning, processing and surface preparation, Méaban tends to handle the whole chain. In addition to strengthening the aviation market, which accounts for 70% of the activity, Babb Co also opens up new avenues. Those of energy and nuclear. "Babb Co is already present in the nondestructive testing of parts of electric reactors, nuclear and oil platforms," adds Frederic Lescure. If Babb Co currently generates 20% of its sales abroad, the support of the holding company would enable it to realize its ambitions. "And as with the subsidiary Socomore, Babb Co put on the planet world," said Chairman and CEO. To support these developments, Frédéric Lescure carried out a capital increase of three million at end 2011 total alongside CM-CIC Capital Finance, a new shareholder.
Diversification in the pharmaceutical industry
While the production equipment of the subsidiary Socomore must move before the month of June in Elven, the new plant area Gohélis, Méaban reinvests in its facility Vannes. "We were ready to sell the site last year," says Frédéric Lescure. Contec and then, with U.S. partner Méaban who has signed a joint venture in 2008, proposes to move to France at the production site of the European standard for sterile products destined for the pharmaceutical industry. A new market for Méaban who seized the opportunity to diversify. "Will this product wipes, bulk materials and prepregs packed to ensure their sterilization," said Clarissa Lesage, marketing manager. "These products will then be used to clean the chain drug manufacturing." The pharmaceutical industry is increasingly regulated and controlled, Méaban plays its expertise in providing solutions to critical and approved. With qualified and certified products. Therefore, a new envelope will be devoted to the redevelopment of the site area of Prat to install production lines.
"Like a ghost train"
Frédéric Lescure admits today, it advances by trial and error. The backlog of Socomore is measured only ten days. "It's like a ghost train, we always hope we will succeed in your next turn," he recalls. "Before the violent crisis of 2008, our luxury was to have visibility on orders." However, the Chairman and CEO of Méaban does not sail in sight. The year 2011 was in his "exceptional" and finally revives to growth after two years of "hangover" with peaks at - 40% of turnover. He knows now what to expect. The aviation market is booming, and displays of aircraft production rates a factor of two. "In 2016, there will be four times as many aircraft surfaces to be treated in 2008," calculates Frédéric Lescure. "The planes will be more and bigger." Airbus' largest customer Méaban must build almost four A380s per month by four years and 42 A320s. For Méaban, it is as much surface preparation, cleaning, process. "A beginning of corrosion on a car door, it does not matter. Just annoying. On a plane, it's something else. Everything is critique.Préparer the surface of an A380 to paste a window has to be perfect. If the door falls in mid-flight, there is more air ... "The room for error or negligence is not allowed. That is why the products manufactured by the group are Méaban civil liability insurance of $ 100 million.